Article
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
1 May 2009
Abstract excerpt
BACKGROUND: The presence of aberrantly methylated SEPT9 DNA in plasma is highly correlated with the occurrence of colorectal cancer. We report the development of a new SEPT9 biomarker assay and its validation in case-control studies. The development of such a minimally invasive blood-based test may help to reduce the current gap in screening coverage. METHODS: A new SEPT9 DNA methylation assay was developed for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
